📣 VC round data is live. Check it out!

P3 Health Partners Valuation Multiples

Discover revenue and EBITDA valuation multiples for P3 Health Partners and similar public comparables like Third Age Health Services, Biote, DocGo, Maternus-Kliniken and more.

P3 Health Partners Overview

About P3 Health Partners

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.


Founded

2020

HQ

United States

Employees

360

Website

p3hp.org

Financials (LTM)

Revenue: $1B
EBITDA: ($77M)

EV

$341M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

P3 Health Partners Financials

P3 Health Partners reported last 12-month revenue of $1B and negative EBITDA of ($77M).

In the same LTM period, P3 Health Partners generated ($77M) in EBITDA losses and had net loss of ($116M).

Revenue (LTM)


P3 Health Partners P&L

In the most recent fiscal year, P3 Health Partners reported revenue of $1B and EBITDA of ($149M).

P3 Health Partners is unprofitable as of last fiscal year, with EBITDA margin of (10%) and net margin of (10%).

See analyst estimates for P3 Health Partners
LTMLast FY202320242025202620272028
Revenue$1B$1B$1B$2B$1B
EBITDA($77M)($149M)($81M)($198M)($182M)
EBITDA Margin(5%)(10%)(6%)(13%)(12%)
EBIT Margin(12%)(19%)(13%)(21%)(19%)
Net Profit($116M)($148M)($58M)($136M)($148M)
Net Margin(8%)(10%)(5%)(9%)(10%)
Net Debt—$248M———

Financial data powered by Morningstar, Inc.

P3 Health Partners Stock Performance

P3 Health Partners has current market cap of $44M, and enterprise value of $341M.

Market Cap Evolution


P3 Health Partners' stock price is $13.20.

P3 Health Partners share price increased by 376.5% in the last 30 days, and by 78.6% in the last year.

P3 Health Partners has an EPS (earnings per share) of $-44.48.

See more trading valuation data for P3 Health Partners
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$341M$44M0.0%376.5%522.6%78.6%$-44.48

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

P3 Health Partners Valuation Multiples

P3 Health Partners trades at 0.2x EV/Revenue multiple, and (4.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for P3 Health Partners

EV / Revenue (LTM)


P3 Health Partners Financial Valuation Multiples

As of May 26, 2026, P3 Health Partners has market cap of $44M and EV of $341M.

P3 Health Partners has a P/E ratio of (0.4x).

LTMLast FY202320242025202620272028
EV/Revenue0.2x0.2x0.3x0.2x0.2x
EV/EBITDA(4.4x)(2.3x)(4.2x)(1.7x)(1.9x)
EV/EBIT(1.9x)(1.3x)(2.0x)(1.1x)(1.3x)
P/E(0.4x)(0.3x)(0.8x)(0.3x)(0.3x)
EV/FCF—(3.7x)(4.4x)(3.1x)(3.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified P3 Health Partners Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

P3 Health Partners Margins & Growth Rates

P3 Health Partners grew revenue by 4% but EBITDA decreased by 120% in the last fiscal year.

In the most recent fiscal year, P3 Health Partners reported EBITDA margin of (10%) and net margin of (10%).

See estimated margins and future growth rates for P3 Health Partners

P3 Health Partners Margins

Last FY202420252026202720282029
EBITDA Margin(10%)(13%)(12%)2%
EBIT Margin(19%)(21%)(19%)(3%)
Net Margin(10%)(9%)(10%)(4%)
FCF Margin(6%)(7%)(6%)—

P3 Health Partners Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%18%(3%)4%
EBITDA Growth(120%)144%(8%)(117%)
EBIT Growth(83%)86%(14%)(83%)
Net Profit Growth(54%)135%9%(54%)
FCF Growth—41%(17%)—

Data powered by FactSet, Inc. and Morningstar, Inc.

P3 Health Partners Operational KPIs

P3 Health Partners' revenue per employee in the last FY averaged $4.1M, while opex per employee averaged $4.8M for the same period.

P3 Health Partners' Rule of 40 is 6% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

P3 Health Partners' Rule of X is 13% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for P3 Health Partners
LTMLast FY202320242025202620272028
Rule of 401%6%———
Bessemer Rule of X10%13%———
Revenue per Employee—$4.1M———
Opex per Employee—$4.8M———
S&M Expenses to Revenue0%0%0%0%0%
G&A Expenses to Revenue7%7%10%8%7%
Opex to Revenue—119%113%121%119%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

P3 Health Partners Competitors

P3 Health Partners competitors include Third Age Health Services, Biote, DocGo, Maternus-Kliniken, Radius Residential, Joint, Eureka Group Holdings, Oceania Healthcare, Propel Funeral Partners and LNA Sante.

Most P3 Health Partners public comparables operate across Long-Term Care.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Third Age Health Services2.6x—11.1x—
Biote0.9x0.9x3.1x3.5x
DocGo0.2x0.2x(1.9x)(2.6x)
Maternus-Kliniken1.7x—18.6x—
Radius Residential1.8x1.5x10.4x8.7x
Joint2.0x1.9x8.4x8.7x
Eureka Group Holdings7.9x7.2x10.8x18.0x
Oceania Healthcare4.4x3.3x16.8x16.6x

This data is available for Pro users. Sign up to see all P3 Health Partners competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About P3 Health Partners

When was P3 Health Partners founded?P3 Health Partners was founded in 2020.
Where is P3 Health Partners headquartered?P3 Health Partners is headquartered in United States.
How many employees does P3 Health Partners have?As of today, P3 Health Partners has over 360 employees.
Who is the CEO of P3 Health Partners?P3 Health Partners' CEO is Aric Coffman.
Is P3 Health Partners publicly listed?Yes, P3 Health Partners is a public company listed on Nasdaq.
What is the stock symbol of P3 Health Partners?P3 Health Partners trades under PIII ticker.
When did P3 Health Partners go public?P3 Health Partners went public in 2021.
Who are competitors of P3 Health Partners?P3 Health Partners main competitors include Third Age Health Services, Biote, DocGo, Maternus-Kliniken, Radius Residential, Joint, Eureka Group Holdings, Oceania Healthcare, Propel Funeral Partners, LNA Sante.
What is the current market cap of P3 Health Partners?P3 Health Partners' current market cap is $44M.
What is the current revenue of P3 Health Partners?P3 Health Partners' last 12 months revenue is $1B.
What is the current revenue growth of P3 Health Partners?P3 Health Partners revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of P3 Health Partners?Current revenue multiple of P3 Health Partners is 0.2x.
Is P3 Health Partners profitable?No, P3 Health Partners is not profitable.
What is the current EBITDA of P3 Health Partners?P3 Health Partners has negative EBITDA and is not profitable.
What is P3 Health Partners' EBITDA margin?P3 Health Partners' last 12 months EBITDA margin is (5%).
What is the current EV/EBITDA multiple of P3 Health Partners?Current EBITDA multiple of P3 Health Partners is (4.4x).
How many companies P3 Health Partners has acquired to date?P3 Health Partners hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies P3 Health Partners has invested to date?P3 Health Partners hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to P3 Health Partners

Lists including P3 Health Partners

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial